New partners for Luspatercept in β-thalassemia

Am J Hematol. 2024 Jul;99(7):1217-1219. doi: 10.1002/ajh.27362. Epub 2024 May 16.

Author

Francesca Vinchi^{1

2}

Affiliations

¹ Iron Research Laboratory, New York Blood Center, New York, USA.
² Dept. of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, USA.

PMID: 38752378
DOI: 10.1002/ajh.27362

No abstract available

Publication types

Comment

MeSH terms

Activin Receptors, Type II / therapeutic use
Humans
Immunoglobulin Fc Fragments* / therapeutic use
Recombinant Fusion Proteins* / therapeutic use
beta-Thalassemia* / drug therapy

Substances

luspatercept
Recombinant Fusion Proteins
Immunoglobulin Fc Fragments
Activin Receptors, Type II